Statistics
Publications
2
Citations
29
H-Index
2
Active since
2022
Affiliations
Thulaj Meharwade is an author at Montreal Clinical Research Institute specializing in antiproliferative drug action, oncology, and nadh homeostasis.
Publications per year
2022–2023
2
2
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Maxime Parisotto, Nhung Vuong, Paloma Kalegari et al. · Cancers · 2022 · 16 citations · Full text
Medicine, Oncology, Pharmacology +13
Thulaj Meharwade, Loïck Joumier, Maxime Parisotto et al. · Cell Reports · 2023 · 13 citations · Full text
1–2 of 2